Mizuho Securities Downgrades Universal Health to HoldBy Carrie Williams
According to TipRanks.com, Hynes is a 4-star analyst with an average return of 6.0% and a 57.5% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Quest Diagnostics Inc., Envision Healthcare, and Acadia Healthcare.
Universal Health has an analyst consensus of Hold, with a price target consensus of $131.50.
Based on Universal Health’s latest earnings report from March 31, the company posted quarterly revenue of $2.62B and quarterly net profit of $190.8M. In comparison, last year the company earned revenue of $2.44B and had a net profit of $150.3M.
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock. Most recently, in June 2015, Debra Osteen, the SVP of UHS sold 11,305 shares for a total of $1,484,111.
Universal Health Services, Inc. operates as a healthcare management company, which through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. It operates through the Acute Care Hospital Services and Behavioral Health Care Services segments. The company was founded by Alan B. Miller in 1978 and is headquartered in King of Prussia, PA.